中国银屑病患者饮食管理指南（2023）

doi:10.35541/cjd.20220913

中华皮肤科杂志 ›› 2023, Vol. 56 ›› Issue (5): 389-401.doi: 10.35541/cjd.20220913

中国银屑病患者饮食管理指南（2023）

中国医师协会皮肤科医师分会中华医学会皮肤性病学分会空军军医大学西京医院中国银屑病患者饮食指南制订工作组

中国医师协会皮肤科医师分会中华医学会皮肤性病学分会空军军医大学西京医院中国银屑病患者饮食指南制订工作组

收稿日期:2022-12-23 修回日期:2023-02-23 发布日期:2023-05-04
通讯作者: 王刚 E-mail:zhugn@fmmu.edu.cn
基金资助:
陕西省重点研发计划课题（2022ZDLSF03-14）

Dietary guideline for patients with psoriasis in China （2023）

China Dermatologist Association; Chinese Society of Dermatology; Xijing Hospital, Air Force Medical University; Chinese Dietary Guideline for Psoriasis Patients Task Force

China Dermatologist Association; Chinese Society of Dermatology; Xijing Hospital, Air Force Medical University; Chinese Dietary Guideline for Psoriasis Patients Task Force

Received:2022-12-23 Revised:2023-02-23 Published:2023-05-04
Contact: Wang Gang E-mail:zhugn@fmmu.edu.cn
Supported by:
Shaanxi Key Research and Development Program（2022ZDLSF03-14）

摘要/Abstract

摘要： 【摘要】我国银屑病患病人数不断上升，饮食是影响患者生活质量的关键因素之一，但目前仍缺乏规范的指导意见，制订一部循证饮食管理指南具有重要的意义。本指南由中国医师协会皮肤科医师分会、中华医学会皮肤性病学分会联合发起，由皮肤科、营养科及循证方法学专家组成工作组，依据临床循证指南的规范流程，制订了本指南。本指南针对皮肤科医生和患者较为关注的12个临床问题作出了17条循证推荐意见，旨在为银屑病患者提供更加科学、合理的饮食建议。

关键词: 银屑病, 膳食, 指南

Abstract: 【Abstract】 The prevalence of psoriasis in China is witnessing an upward trend in recent years. Diet is one of the vital factors associated with patients′ quality of life, but there is still a lack of standardized instructions. Hence, it is of great importance to develop an evidence-based guideline for dietary management among Chinese patients with psoriasis. This guideline was jointly endorsed by the China Dermatologist Association and the Chinese Society of Dermatology. A working group composed of experts in the fields of dermatology, nutriology, and evidence-based methodology developed this guideline following the standardized process of formulating clinical evidence-based guidelines. This guideline provides 17 evidence-based recommendations on 12 clinical issues of great concern to dermatologists and patients, aiming to provide more scientific and reasonable dietary interventions for patients with psoriasis.

Key words: Psoriasis, Diet, Guideline

中国医师协会皮肤科医师分会中华医学会皮肤性病学分会空军军医大学西京医院中国银屑病患者饮食指南制订工作组. 中国银屑病患者饮食管理指南（2023）[J]. 中华皮肤科杂志, 2023,56(5):389-401. doi:10.35541/cjd.20220913

China Dermatologist Association, Chinese Society of Dermatology, Xijing Hospital, Air Force Medical University, Chinese Dietary Guideline for Psoriasis Patients Task Force. Dietary guideline for patients with psoriasis in China （2023）[J]. Chinese Journal of Dermatology, 2023, 56(5): 389-401.doi:10.35541/cjd.20220913

参考文献 78

［1］	Armstrong A W, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review［J］. JAMA, 2020,323（19）:1945⁃1960. doi: 10.1001/jama.2020.4006.
［2］	Leung YY, Tam LS, Li EK. The perspective on psoriatic arthritis in Asia［J］. Curr Rheumatol Rep, 2011,13（4）:369⁃375. doi: 10.1007/s11926⁃011⁃0183⁃9.
［3］	Ding X, Wang T, Shen Y, et al. Prevalence of psoriasis in China: a population⁃based study in six cities［J］. Eur J Dermatol, 2012,22（5）:663⁃667. doi: 10.1684/ejd.2012.1802.
［4］	Griffiths C, Armstrong AW, Gudjonsson JE, et al. Psoriasis［J］. Lancet, 2021,397（10281）:1301⁃1315. doi: 10.1016/S0140⁃6736（20）32549⁃6.
［5］	Holmannova D, Borska L, Andrys C, et al. The impact of psoriasis and metabolic syndrome on the systemic inflammation and oxidative damage to nucleic acids［J］. J Immunol Res, 2020,2020:1⁃9. doi: 10.1155/2020/7352637.
［6］	Polic M V, Miskulin M, Smolic M, et al. Psoriasis severity⁃a risk factor of insulin resistance independent of metabolic syndrome［J］. Int J Environ Res Public Health, 2018,15（7）:1486. doi: 10.3390/ijerph15071486.
［7］	Zusman E Z, Howren A M, Park J Y E, et al. Epidemiology of depression and anxiety in patients with psoriatic arthritis: a systematic review and meta⁃analysis［J］. Semin Arthritis Rheum, 2020, 50（6）: 1481⁃1488. doi: 10.1016/j.semarthrit.2020.02.001.
［8］	Elmets CA, Leonardi CL, Davis D, et al. Joint AAD⁃NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities［J］. J Am Acad Dermatol, 2019,80（4）:1073⁃1113. doi: 10.1016/j.jaad.2018.11. 058.
［9］	Wolters M. Diet and psoriasis: experimental data and clinical evidence［J］. Br J Dermatol, 2005,153（4）:706⁃714. doi: 10. 1111/j.1365⁃2133.2005.06781.x.
［10］	Garbicz J, Całyniuk B, Górski M, et al. Nutritional therapy in persons suffering from psoriasis［J］. Nutrients, 2021,14（1）:119. doi: 10.3390/nu14010119.
［11］	Afifi L, Danesh M J, Lee K M, et al. Dietary behaviors in psoriasis: patient⁃reported outcomes from a u.s. national survey［J］. Dermatol Ther （Heidelb）, 2017,7（2）:227⁃242. doi: 10.1007/ s13555⁃017⁃0183⁃4.
［12］	Bridgman AC, Qureshi AA, Li T, et al. Inflammatory dietary pattern and incident psoriasis, psoriatic arthritis, and atopic dermatitis in women: a cohort study［J］. J Am Acad Dermatol, 2019,80（6）:1682⁃1690. doi: 10.1016/j.jaad.2019.02.038.
［13］	Drucker AM, Qureshi AA, Thompson JM, et al. Gluten intake and risk of psoriasis, psoriatic arthritis, and atopic dermatitis among United States women［J］. J Am Acad Dermatol, 2020,82（3）:661⁃665. doi: 10.1016/j.jaad.2019.08.007.
［14］	Ford A R, Siegel M, Bagel J, et al. Dietary recommendations for adults with psoriasis or psoriatic arthritis from the medical board of the national psoriasis foundation: a systematic review［J］. JAMA Dermatol, 2018, 154（8）: 934⁃950. doi: 10.1001/jamadermatol. 2018.1412.
［15］	朱冠男, 徐峰, 俞晨, 等. 对中国皮肤科医生关于饮食影响银屑病的认知调查: 一项横断面分析［J］. 中华皮肤科杂志, 2021,54（10）:891⁃897. doi: 10.35541/cjd.20200540.
［16］	朱慧琴, 仲珣, 王洋, 等. 银屑病312例与代谢综合征相关性的临床分析［J］. 中国皮肤性病学杂志, 2019,33（4）:425⁃430. doi: 10.13735/j.cjdv.1001⁃7089.201804097.
［17］	毛荣超, 陈新春, 卢玉龙, 等. 贵州黔南地区农村少数民族居民银屑病患病现状及其危险因素分析［J］. 中国公共卫生, 2019,35（1）:34⁃37. doi: 10.11847/zgggws1117664.
［18］	Lenoir H, Erbland A, Lumens D, et al. Trapeziectomy and ligament reconstruction tendon interposition after failed trapeziometacarpal joint replacement［J］. Hand Surg Rehabil, 2016,35（1）:21⁃26. doi: 10.1016/j.hansur.2015.09.002.
［19］	Ogawa K, Stuart P E, Tsoi L C, et al. A transethnic mendelian randomization study identifies causality of obesity on risk of psoriasis［J］. J Invest Dermatol, 2019,139（6）:1397⁃1400. doi: 10.1016/j.jid.2018.11.023.
［20］	Eder L, Thavaneswaran A, Chandran V, et al. Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis［J］. Ann Rheum Dis, 2015,74（5）:813⁃817. doi: 10. 1136/annrheumdis⁃2013⁃204448.
［21］	Enos C W, Ramos V L, McLean R R, et al. Comorbid obesity and history of diabetes are independently associated with poorer treatment response to biologics at 6 months: a prospective analysis in corrona psoriasis registry［J］. J Am Acad Dermatol, 2022,86（1）:68⁃76. doi: 10.1016/j.jaad.2021.06.883.
［22］	Paroutoglou K, Papadavid E, Christodoulatos G S, et al. Deciphering the association between psoriasis and obesity: current evidence and treatment considerations［J］. Curr Obes Rep, 2020,9（3）:165⁃178. doi: 10.1007/s13679⁃020⁃00380⁃3.
［23］	Aune D, Snekvik I, Schlesinger S, et al. Body mass index, abdominal fatness, weight gain and the risk of psoriasis: a systematic review and dose⁃response meta⁃analysis of prospective studies［J］. Eur J Epidemiol, 2018,33（12）:1163⁃1178. doi: 10.1007/s10654⁃018⁃0366⁃z.
［24］	Phan K, Lee G, Fischer G. Pediatric psoriasis and association with cardiovascular and metabolic comorbidities: systematic review and meta⁃analysis［J］. Pediatr Dermatol, 2020,37（4）:661⁃669. doi: 10.1111/pde.14208.
［25］	Xie W, Huang H, Deng X, et al. Modifiable lifestyle and environmental factors associated with onset of psoriatic arthritis in patients with psoriasis: a systematic review and meta⁃analysis of observational studies［J］. J Am Acad Dermatol, 2021,84（3）:701⁃711. doi: 10.1016/j.jaad.2020.08.060.
［26］	Mahil SK, McSweeney SM, Kloczko E, et al. Does weight loss reduce the severity and incidence of psoriasis or psoriatic arthritis? A Critically Appraised Topic［J］. Br J Dermatol, 2019,181（5）:946⁃953. doi: 10.1111/bjd.17741.
［27］	Mourad A, Straube S, Armijo⁃Olivo S, et al. Factors predicting persistence of biologic drugs in psoriasis: a systematic review and meta⁃analysis［J］. Br J Dermatol, 2019,181（3）:450⁃458. doi: 10.1111/bjd.17738.
［28］	Shan J, Zhang J. Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: a systematic review and meta⁃analysis［J］. Joint Bone Spine, 2019,86（2）:173⁃183. doi: 10.1016/j.jbspin.2018.03.007.
［29］	Ricceri F, Chiricozzi A, Peris K, et al. Successful use of anti⁃IL⁃23 molecules in overweight⁃to⁃obese psoriatic patients: a multicentric retrospective study［J］. Dermatol Ther, 2022,35（11）:e15793. doi: 10.1111/dth.15793.
［30］	Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis［J］. Lancet, 2007,370（9583）:263⁃271. doi: 10.1016/S0140⁃6736（07）61128⁃3.
［31］	Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome［J］. Lancet, 2005,365（9468）:1415⁃1428. doi: 10.1016/S0140⁃6736（05）66378⁃7.
［32］	Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: a systematic review and meta⁃analysis of observational studies［J］. J Am Acad Dermatol, 2013,68（4）:654⁃662. doi: 10.1016/j.jaad.2012.08.015.
［33］	Upala S, Sanguankeo A. Effect of lifestyle weight loss intervention on disease severity in patients with psoriasis: a systematic review and meta⁃analysis［J］. Int J Obes （Lond）, 2015,39（8）:1197⁃1202. doi: 10.1038/ijo.2015.64.
［34］	Jensen P, Zachariae C, Christensen R, et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study［J］. JAMA Dermatol, 2013,149（7）:795⁃801. doi: 10.1001/jamadermatol. 2013.722.
［35］	Jensen P, Zachariae C, Christensen R, et al. Effect of weight loss on the cardiovascular risk profile of obese patients with psoriasis［J］. Acta Derm Venereol, 2014,94（6）:691⁃694. doi: 10.2340/00015555⁃1824.
［36］	Naldi L, Conti A, Cazzaniga S, et al. Diet and physical exercise in psoriasis: a randomized controlled trial［J］. Br J Dermatol, 2014,170（3）:634⁃642. doi: 10.1111/bjd.12735.
［37］	Di Minno MN, Peluso R, Iervolino S, et al. Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers［J］. Ann Rheum Dis, 2014,73（6）:1157⁃1162. doi: 10.1136/annrheumdis⁃2012⁃202812.
［38］	Guida B, Napoleone A, Trio R, et al. Energy⁃restricted, n⁃3 polyunsaturated fatty acids⁃rich diet improves the clinical response to immuno⁃modulating drugs in obese patients with plaque⁃type psoriasis: a randomized control clinical trial［J］. Clin Nutr, 2014,33（3）:399⁃405. doi: 10.1016/j.clnu.2013.09. 010.
［39］	Al⁃Mutairi N, Nour T. The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial［J］. Expert Opin Biol Ther, 2014,14（6）:749⁃756. doi: 10.1517/14712598. 2014.900541.
［40］	Del Giglio M, Gisondi P, Tessari G, et al. Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator⁃blinded study［J］. Dermatology, 2012,224（1）:31⁃37. doi: 10.1159/0003 35566.
［41］	Gisondi P, Del Giglio M, Di Francesco V, et al. Weight loss improves the response of obese patients with moderate⁃to⁃severe chronic plaque psoriasis to low⁃dose cyclosporine therapy: a randomized, controlled, investigator⁃blinded clinical trial［J］. Am J Clin Nutr, 2008,88（5）:1242⁃1247. doi: 10.3945/ajcn.2008. 26427.
［42］	Kimball AB, Alavian C, Alora⁃Palli M, et al. Weight loss in obese patients with psoriasis can be successfully achieved during a course of phototherapy［J］. J Eur Acad Dermatol Venereol, 2012,26（12）:1582⁃1584. doi: 10.1111/j.1468⁃3083. 2011.04361.x.
［43］	Green A, Shaddick G, Charlton R, et al. Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis［J］. Br J Dermatol, 2020,182（3）:714⁃720. doi: 10.1111/bjd. 18227.
［44］	Patients who misuse alcohol have poorer responses to systemic treatments for psoriasis［J］. Br J Dermatol, 2021,185（5）:e179⁃e198. doi: 10.1111/bjd.20717.
［45］	Wang Q, Luo Y, Chen M, et al. Comparison of behavioral risk factors and cardiometabolic comorbidities of psoriatic arthritis and psoriasis: a case⁃control study in chinese patients［J］. Ther Clin Risk Manage, 2021,17:397⁃404. doi: 10.2147/TCRM.S30 7102.
［46］	郑雨萍, 柏丁兮, 高静, 等. 中国居民银屑病发病危险因素的meta分析［J］. 现代临床医学, 2021,47（6）:433⁃435,440. doi: 10.11851/j.issn.1673⁃1557.2021.06.011.
［47］	Brenaut E, Horreau C, Pouplard C, et al. Alcohol consumption and psoriasis: a systematic literature review［J］. J Eur Acad Dermatol Venereol, 2013,27 Suppl 3:30⁃35. doi: 10.1111/jdv. 12164.
［48］	Zhu KJ, Zhu CY, Fan YM. Alcohol consumption and psoriatic risk: a meta⁃analysis of case⁃control studies［J］. J Dermatol, 2012,39（9）:770⁃773. doi: 10.1111/j.1346⁃8138.2012.01577.x.
［49］	Rodríguez⁃Zúñiga M, García⁃Perdomo HA. Systematic review and meta⁃analysis of the association between psoriasis and metabolic syndrome［J］. J Am Acad Dermatol, 2017,77（4）:657⁃666.e8. doi: 10.1016/j.jaad.2017.04.1133.
［50］	Aune D, Giovannucci E, Boffetta P, et al. Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all⁃cause mortality⁃a systematic review and dose⁃response meta⁃analysis of prospective studies［J］. Int J Epidemiol, 2017,46（3）:1029⁃1056. doi: 10.1093/ije/dyw319.
［51］	尚智伟, 李其林, 付金玲, 等. 国内银屑病发病危险因素的Meta分析［J］. 岭南皮肤性病科杂志, 2009,16（3）:161⁃163. doi: 10.3969/j.issn.1674⁃8468.2009.03.007.
［52］	Ingkapairoj K, Chularojanamontri L, Chaiyabutr C, et al. Dietary habits and perceptions of psoriatic patients: Mediterranean versus Asian diets［J］. J Dermatolog Treat, 2022,33（4）:2290⁃2296. doi: 10.1080/09546634.2021.1959500.
［53］	Naldi L, Parazzini F, Peli L, et al. Dietary factors and the risk of psoriasis. results of an italian case⁃control study［J］. Br J Dermatol, 1996,134（1）:101⁃106. doi: 10.1046/j.1365⁃2133.1996. d01⁃734.x.
［54］	楼燕凤. 银屑病复发相关因素分析及自我管理的探析［D］. 东南大学, 2020.
［55］	徐巧虎. 不同时期银屑病患者流行病学调查及临床资料的多元回归分析［D］. 安徽医科大学, 2019.
［56］	杨桂兰, 苏湘川, 潘之, 等. 甘肃地区寻常性银屑病病情相关因素分析［J］. 实用皮肤病学杂志, 2016,9（2）:101⁃103. doi: 10.11786/sypfbxzz.1674⁃1293.20160206.
［57］	Phan C, Touvier M, Kesse⁃Guyot E, et al. Association between mediterranean anti⁃inflammatory dietary profile and severity of psoriasis: results from the nutrinet⁃santé cohort［J］. JAMA Dermatol, 2018, 154（9）: 1017⁃1024. doi: 10.1001/jamadermatol. 2018.2127.
［58］	Barrea L, Balato N, Di Somma C, et al. Nutrition and psoriasis: is there any association between the severity of the disease and adherence to the mediterranean diet?［J］. J Transl Med, 2015,13（1）:18. doi: 10.1186/s12967⁃014⁃0372⁃1.
［59］	Park MK, Li W, Paek SY, et al. Consumption of polyunsaturated fatty acids and risk of incident psoriasis and psoriatic arthritis from the Nurses′ Health Study II［J］. Br J Dermatol, 2017,177（1）:302⁃306. doi: 10.1111/bjd.15059.
［60］	乔菊, 贾倩楠, 李峰, 等. 寻常性银屑病患者饮食危险因素流行病学调查［J］. 中国皮肤性病学杂志, 2017,31（12）:1301⁃1305. doi: 10.13735/j.cjdv.1001⁃7089.201703159.
［61］	庞春坤, 高婷婷. 中国人群银屑病发病危险因素的Meta分析［J］. 中国麻风皮肤病杂志, 2013,29（4）:235⁃238.
［62］	李玉湘, 傅强, 张秀春, 等. 青海高原地区108例银屑病临床分析［J］. 青海医药杂志, 2012,42（12）:20⁃21.
［63］	袁爱红, 杨骏. 高脂饮食的研究进展［J］. 医学综述, 2012,18（15）:2418⁃2421. doi: 10.3969/j.issn.1006⁃2084.2012.15.026.
［64］	Yazdanpanah MJ, Vahabi⁃Amlashi S, Nematy M, et al. Association of serum lipid profiles and dietary intakes of vitamin E and fiber with psoriasis severity［J］. Caspian J Intern Med, 2021,12（4）:606⁃612. doi: 10.22088/cjim.12.4.606.
［65］	Pinto B, Pereira P, Ramalho R. Characterization of food intake in patients with psoriasis［J］. Clinical Nutrition ESPEN, 2021, 46: S627. doi: 10.1016/j.clnesp.2021.09.242.
［66］	钱园. 寻常性银屑病患者饮食危险因素流行病学调查［J］. 饮食保健, 2018,5（41）:288⁃289. doi: 10.3969/j.issn.2095⁃8439. 2018.41.361. doi: 10.3969/j.issn.2095⁃8439.2018.41.361.
［67］	Leite BF, Morimoto MA, Gomes C, et al. Dietetic intervention in psoriatic arthritis: the DIETA trial［J］. Adv Rheumatol, 2022,62（1）:12. doi: 10.1186/s42358⁃022⁃00243⁃6.
［68］	Kharaeva Z, Gostova E, De Luca C, et al. Clinical and biochemical effects of coenzyme Q（10）, vitamin E, and selenium supplementation to psoriasis patients［J］. Nutrition, 2009,25（3）:295⁃302. doi: 10.1016/j.nut.2008.08.015.
［69］	Gaál J, Lakos G, Szodoray P, et al. Immunological and clinical effects of alphacalcidol in patients with psoriatic arthropathy: results of an open, follow⁃up pilot study［J］. Acta Derm Venereol, 2009,89（2）:140⁃144. doi: 10.2340/00015555⁃0555.
［70］	Madland TM, Björkkjaer T, Brunborg LA, et al. Subjective improvement in patients with psoriatic arthritis after short⁃term oral treatment with seal oil. A pilot study with double blind comparison to soy oil［J］. J Rheumatol, 2006,33（2）:307⁃310.
［71］	Kristensen S, Schmidt EB, Schlemmer A, et al. Beneficial effect of n⁃3 polyunsaturated fatty acids on inflammation and analgesic use in psoriatic arthritis: a randomized, double blind, placebo⁃controlled trial［J］. Scand J Rheumatol, 2018,47（1）:27⁃36. doi: 10.1080/03009742.2017.1287304.
［72］	Veale D J, Torley H I, Richards I M, et al. A double⁃blind placebo controlled trial of efamol marine on skin and joint symptoms of psoriatic arthritis［J］. Rheumatology, 1994,33（10）:954⁃958. doi: 10.1093/rheumatology/33.10.954.
［73］	Graziano M, Rossi M. An update on the cutaneous manifestations of coeliac disease and non⁃coeliac gluten sensitivity［J］. Int Rev Immunol, 2018,37（6）:291⁃300. doi: 10. 1080/08830185.2018.1533008.
［74］	Michaëlsson G, Gerdén B, Ottosson M, et al. Patients with psoriasis often have increased serum levels of IgA antibodies to gliadin［J］. Br J Dermatol, 1993,129（6）:667⁃673. doi: 10.1111/j.1365⁃2133.1993.tb03329.x.
［75］	Bell K A, Pourang A, Mesinkovska N A, et al. The effect of gluten on skin and hair: a systematic review［J］. Dermatol Online J, 2021, 27（4）: 13030/qt2qz916r0. doi: 10.5070/D3274053148.
［76］	Michaëlsson G, Kristjánsson G, Pihl Lundin I, et al. Palmoplantar pustulosis and gluten sensitivity: a study of serum antibodies against gliadin and tissue transglutaminase, the duodenal mucosa and effects of gluten⁃free diet［J］. Br J Dermatol, 2007,156（4）:659⁃666. doi: 10.1111/j.1365⁃2133.2006. 07725.x.
［77］	Stegenga H, Haines A, Jones K, et al. Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance［J］. BMJ, 2014,349:g6608. doi: 10.1136/bmj.g6608.
［78］	Hoelscher DM, Kirk S, Ritchie L, et al. Position of the Academy of Nutrition and Dietetics: interventions for the prevention and treatment of pediatric overweight and obesity［J］. J Acad Nutr Diet, 2013,113（10）:1375⁃1394. doi: 10.1016/j.jand.2013.08.004.

[1]	蒋晓妍高敏张晓艳刘宁远. 白细胞介素17和白细胞介素23拮抗剂治疗脓疱型银屑病研究进展[J]. 中华皮肤科杂志, 2023, 56(7): 689-692.
[2]	唐志铭荆梦晴陆鹭单霄张翠侠张晓宇孟飒. 犀地凉血方通过LncRNA NEAT1/miR-485-5p/ STAT3调控网络对HaCaT细胞增殖、凋亡影响的研究[J]. 中华皮肤科杂志, 2023, 56(7): 642-650.
[3]	中华医学会皮肤性病学分会银屑病专业委员会. 中国银屑病诊疗指南（2023版）[J]. 中华皮肤科杂志, 2023, 56(7): 573-625.
[4]	闪莹常晓彤左亚刚. 自身免疫性疱病的表位扩展现象[J]. 中华皮肤科杂志, 2023, 56(7): 702-705.
[5]	金利平朱武鲁艳刘盼盼谭敏佳王英杨晶徐黎聪胡琨匡叶红. 饮食干预治疗银屑病的相关进展[J]. 中华皮肤科杂志, 2023, 56(4): 357-360.
[6]	连盼盼刘军苏忠兰王宏伟. 过氧化物酶体增殖物激活受体γ对皮肤生理功能和病理过程的影响[J]. 中华皮肤科杂志, 2023, 56(4): 365-368.
[7]	刘小扬赵琰蔡林张建中. 银屑病患者白细胞介素17拮抗剂治疗后出现特应性皮炎样皮疹4例分析与文献回顾[J]. 中华皮肤科杂志, 2023, 0(3): 20210794-e20210794.
[8]	何谐栗玉珍. 靶向JAK-STAT信号通路治疗银屑病的研究进展[J]. 中华皮肤科杂志, 2023, 56(3): 273-278.
[9]	阮诗钒张鹏林婷婷罗仁炜鲍思怡薛晨瑶童泽群张亮亮龚婷纪超. 寻常型银屑病与血脂异常的相关性研究[J]. 中华皮肤科杂志, 2023, 0(3): 20220322-e20220322.
[10]	中华医学会皮肤性病学分会银屑病专业委员会. 银屑病生物制剂达标治疗专家共识[J]. 中华皮肤科杂志, 2023, 56(3): 191-203.
[11]	周健俞晨王刚. 司库奇尤单抗治疗13例难治性局限性脓疱型银屑病的临床疗效与安全性观察[J]. 中华皮肤科杂志, 2023, 56(3): 247-251.
[12]	胡琨杨晶王巧林陈军臣张谧朱武张斌窦冠珅 Wendong Chen, 匡叶红. [开放获取] 依奇珠单抗治疗银屑病短期疗效的单中心病例回顾性研究[J]. 中华皮肤科杂志, 2023, 56(3): 210-215.
[13]	陈良宏孙艳王敬玉吴严. 本维莫德在皮肤病中的研究进展[J]. 中华皮肤科杂志, 2023, 0(2): 20210875-e20210875.
[14]	李秀珍徐秀莲. 白细胞介素23抑制剂治疗对银屑病共病的影响[J]. 中华皮肤科杂志, 2023, 0(2): 20210809-e20210809.
[15]	杨琦郑捷. 生物制剂治疗对银屑病相关心血管疾病的影响[J]. 中华皮肤科杂志, 2023, 56(2): 165-169.

中国银屑病患者饮食管理指南（2023）

Dietary guideline for patients with psoriasis in China （2023）

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 78

相关文章 15

Metrics

本文评价

推荐阅读 10